Leah I. Leinbach

463 total citations
14 papers, 368 citations indexed

About

Leah I. Leinbach is a scholar working on Periodontics, Oncology and Hematology. According to data from OpenAlex, Leah I. Leinbach has authored 14 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Periodontics, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Leah I. Leinbach's work include Oral microbiology and periodontitis research (4 papers), CAR-T cell therapy research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Leah I. Leinbach is often cited by papers focused on Oral microbiology and periodontitis research (4 papers), CAR-T cell therapy research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Leah I. Leinbach collaborates with scholars based in United States, Australia and Israel. Leah I. Leinbach's co-authors include Nicole A. Aqui, Theresa A. Colligon, James L. Riley, Daniel J. Powell, Susan M. Domchek, Sunil Martin, Charles H. Pletcher, Andrew J. Rech, Kevin R. Fox and Rosemarie Mick and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Leah I. Leinbach

12 papers receiving 363 citations

Peers

Leah I. Leinbach
Leah I. Leinbach
Citations per year, relative to Leah I. Leinbach Leah I. Leinbach (= 1×) peers Elisabet Nylander

Countries citing papers authored by Leah I. Leinbach

Since Specialization
Citations

This map shows the geographic impact of Leah I. Leinbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah I. Leinbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah I. Leinbach more than expected).

Fields of papers citing papers by Leah I. Leinbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah I. Leinbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah I. Leinbach. The network helps show where Leah I. Leinbach may publish in the future.

Co-authorship network of co-authors of Leah I. Leinbach

This figure shows the co-authorship network connecting the top 25 collaborators of Leah I. Leinbach. A scholar is included among the top collaborators of Leah I. Leinbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah I. Leinbach. Leah I. Leinbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Leinbach, Leah I., et al.. (2025). Oral microbiome alterations after cancer treatment: a scoping review and analysis. Medical Oncology. 42(10). 432–432. 1 indexed citations
2.
Leinbach, Leah I., et al.. (2025). Oral Health Characteristics 2 Years following Allogeneic Cell Transplant. Journal of Dental Research. 104(10). 1061–1068.
3.
Leinbach, Leah I., et al.. (2025). Pharmacologic Management of Non‐Traumatic Dental Conditions in US Emergency Departments, 2018–2022. Journal of Public Health Dentistry. 85(3). 220–230. 1 indexed citations
4.
Park, Bongsoo, Hyunwook Koh, Hermes Reyes-Caballero, et al.. (2023). The mediating roles of the oral microbiome in saliva and subgingival sites between e-cigarette smoking and gingival inflammation. BMC Microbiology. 23(1). 35–35. 23 indexed citations
5.
Tuan, Wen‐Jan, et al.. (2022). Assessing Risks of Early Childhood Caries in Primary Care Practice Using Electronic Health Records and Neighborhood Data. Journal of Public Health Management and Practice. 29(2). 178–185. 3 indexed citations
6.
Willink, Amber, Nicholas S. Reed, Bonnielin K. Swenor, et al.. (2020). Dental, Vision, And Hearing Services: Access, Spending, And Coverage For Medicare Beneficiaries. Health Affairs. 39(2). 297–304. 40 indexed citations
7.
Leinbach, Leah I. & Amber Willink. (2020). Oral Health in Medicare. JAMA. 324(13). 1288–1288.
8.
Gupta, Avni, et al.. (2017). Length of Stay and Cost in Patients Undergoing Orthognathic Surgery: Does Surgeon Volume Matter?. Journal of Oral and Maxillofacial Surgery. 75(9). 1948–1957. 16 indexed citations
9.
Rech, Andrew J., Rosemarie Mick, Sunil Martin, et al.. (2012). CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients. Science Translational Medicine. 4(134). 134ra62–134ra62. 271 indexed citations
10.
Schuster, Stephen J., Chitra Hosing, Elizabeth J. Shpall, et al.. (2011). Adoptive Immunotherapy with Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy in Patients with Chronic Lymphocytic Leukemia. Blood. 118(21). 2855–2855. 1 indexed citations
11.
Schuster, Stephen J., Chitra Hosing, Elizabeth J. Shpall, et al.. (2011). Adoptive immunotherapy with autologous CD3/CD28-costimulated T cells after fludarabine-based chemotherapy in patients with chronic lymphocytic leukemia.. Journal of Clinical Oncology. 29(15_suppl). 2557–2557. 1 indexed citations
12.
Aqui, Nicole A., Leah I. Leinbach, Elise A. Chong, et al.. (2010). Changes in regulatory T-cells in responding and non-responding patients with indolent B-cell or mantle cell lymphomas during treatment with lenalidomide, dexamethasone, and rituximab.. Journal of Clinical Oncology. 28(15_suppl). 8085–8085. 1 indexed citations
13.
Ahmadi, Tahamtan, Elise A. Chong, Amanda Gordon, et al.. (2010). Phase II Trial of Lenalidomide - Dexamethasone - Rituximab In Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab. Blood. 116(21). 3962–3962. 9 indexed citations
14.
Ahmadi, Tahamtan, Elise A. Chong, Nicole A. Aqui, et al.. (2009). Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab.. Blood. 114(22). 1700–1700. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026